GW Pharmaceuticals receives European Commission approval for EPIDYOLEX®

GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex. Read the PDF document here. [...]